Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor 51B5 (OR51B5) is a member of the olfactory receptor family, encoded by a single-exon gene on chromosome 11 (11p15.4). Like other olfactory receptors, it possesses a seven-transmembrane domain characteristic of GPCRs and mediates signal transduction by interacting with odorant molecules, activating intracellular G protein signaling cascades. While primarily expressed in the olfactory epithelium, OR51B5 is also expressed in other tissues, including skin and certain cancers. Recent studies highlight its additional function as a tumor suppressor in esophageal cancer: transcriptional silencing of OR51B5 by chromatin modification leads to enhanced N-Ras activity and tumor cell proliferation, while its activation increases intracellular Ca²⁺ and suppresses malignancy, indicating relevance as a novel therapeutic target and prognostic marker in cancer. OR51B5 also participates in keratinocyte migration, relevant to wound healing.
For putative ligands (isononyl alcohol): activation of OR51B5 increases intracellular Ca²⁺ signaling and reduces N-Ras expression, inhibiting cell proliferation and metastasis; G protein–mediated signal transduction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor 51B5 (OR51B5).